Bridges from hospitals to the laboratory: Genetic portraits of methicillin-resistant Staphylococcus aureus clones

FEMS Immunology and Medical Microbiology

Volumn 40, Issue 2, 2004, Pages 101-111

  Aires De Sousa, Marta ^a   De Lencastre, Hermínia ^a,b  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

CA MRSA; International MRSA clones; MRSA typing; Multidrug susceptible MRSA; Origin of MRSA; Sporadic MRSA; Vancomycin resistance

Indexed keywords

COTRIMOXAZOLE; FUSIDIC ACID; GENTAMICIN; LINCOMYCIN; METICILLIN; MINOCYCLINE; PENICILLIN BINDING PROTEIN 2A; PEPTIDOGLYCAN; PRISTINAMYCIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM MUTANT; CHROMOSOME INSERTION; COMMUNICABLE DISEASE; COST OF ILLNESS; CROSS LINKING; EPIDEMIC; GENE CASSETTE; GENE LOCUS; GENE TRANSFER; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INFECTION SENSITIVITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR CLONING; MOLECULAR EVOLUTION; MOLECULAR MECHANICS; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PORTUGAL; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SHORT SURVEY; STAPHYLOCOCCUS INFECTION; TREATMENT FAILURE;

EID: 1342281641     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00370-5     Document Type: Short Survey

References (91)

1. Kluytmans J., van Belkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms and associated risks. Clin. Microbiol. Rev. 10:1997;505-520.
2. Tenover, F.C. and Gaynes, R.P. (2000) The epidemiology of Staphylococcus infections. In: Gram-positive Pathogens (Fischetti, V.A., Novick, R.P., Ferretti, J.J., Portnoy, D.A. and Rood, J.I., Eds.), pp. 414-421. American Society for Microbiology, Washington, DC.
3. Jevons M.P. 'Celbenin'-resistant staphylococci. Br. Med. J. 1:1961;124-125.
4. Haley R.W., Hightower A.W., Khabbaz R.F., Thornsberry C., Martone W.J., Allen J.R., Hughes J.M. The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann. Intern. Med. 97:1982;297-308.
5. Hartman B., Tomasz A. Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 19:1981;726-735.
6. Pinho M.G., de Lencastre H., Tomasz A. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. Proc. Natl. Acad. Sci. USA. 98:2001;10886-10891.
7. Wu S., Piscitelli C., de Lencastre H., Tomasz A. Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin susceptible strain of Staphylococcus sciuri. Microb. Drug Resist. 2:1996;435-441.
8. Couto I., de Lencastre H., Severina E., Kloos W., Webster J.A., Hubner R.J., Sanches I.S., Tomasz A. Ubiquitous presence of a mecA homologue in natural isolates of Staphylococcus sciuri. Microb. Drug Resist. 2:1996;377-391.
9. Wu S.W., de Lencastre H., Tomasz A. Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus. J. Bacteriol. 183:2001;2417-2424.
10. Wielders C.L., Vriens M.R., Brisse S., de Graaf-Miltenburg L.A., Troelstra A., Fleer A., Schmitz F.J., Verhoef J., Fluit A.C. In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected]. Lancet. 357:2001;1674-1675.
11. Ito T., Katayama Y., Hiramatsu K. Cloning and nucleotide sequence determination of the entire mec DNA of pre-methicillin-resistant Staphylococcus aureus N315. Antimicrob. Agents Chemother. 43:1999;1449-1458.
12. Katayama Y., Ito T., Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin-resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 44:2000;1549-1555.
13. Ito T., Katayama Y., Asada K., Mori N., Tsutsumimoto K., Tiensasitorn C., Hiramatsu K. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:2001;1323-1336.
14. Oliveira D.C., Tomasz A., de Lencastre H. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb. Drug Resist. 7:2001;349-361.
15. Okuma K., Iwakawa K., Turnidge J.D., Grubb W.B., Bell J.M., O'Brien F.G., Coombs G.W., Pearman J.W., Tenover F.C., Kapi M., Tiensasitorn C., Ito T., Hiramatsu K. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J. Clin. Microbiol. 40:2002;4289-4294.
16. Archer G.L., Thanassi J.A., Niemeyer D.M., Pucci M.J. Characterization of IS1272, an insertion sequence-like element from Staphylococcus haemolyticus. Antimicrob. Agents Chemother. 40:1996;924-929.
17. Oliveira D.C., Tomasz A., de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect. Dis. 2:2002;180-189.
18. Musser J.M., Kapur V. Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination. J. Clin. Microbiol. 30:1992;2058-2063.
19. Fitzgerald J.R., Sturdevant D.E., Mackie S.M., Gill S.R., Musser J.M. Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc. Natl. Acad. Sci. USA. 98:2001;8821-8826.
20. Enright M.C., Robinson D.A., Randle G., Feil E.J., Grundmann H., Spratt B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA. 99:2002;7687-7692.
21. NNIS, National Nosocomial Infections Surveillance System Report (2002) Data summary from January 1992 to June 2002, issued August 2002. Am. J. Infect. Control 30, 458-475.
22. NNIS, National Nosocomial Infections Surveillance System Report (2001) Data summary from January 1992-June 2001, issued August 2001. Am. J. Infect. Control 29, 404-421.
23. Witte W., Kresken M., Braulke C., Cuny C. Increasing incidence and widespread dissemination of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals in central Europe, with special reference to German hospitals. Clin. Microbiol. Infect. 3:1997;414-422.
24. Diekema D.J., Pfaller M.A., Schmitz F.J., Smayevsky J., Bell J., Jones R.N., Beach M. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32:(Suppl. 2):2001;S114-S132.
25. Bell J.M., Turnidge J.D. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999. Antimicrob. Agents Chemother. 46:2002;879-881.
26. EARSS, European Antimicrobial Resistance Surveillance System (2002) Annual report EARSS - 2001, Bilthoven. Available at http://www.earss.rivm.nl .
27. Woodley D.W., Hall W.H. Treatment of severe staphylococcal infections with vancomycin. Ann. Intern. Med. 55:1961;235-249.
28. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., Tenover F.C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:1997;135-136.
29. Walsh T.R., Howe R.A. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu. Rev. Microbiol. 56:2002;657-675.
30. Hiramatsu K., Aritaka N., Hanaki H., Kawasaki S., Hosoda Y., Hori S., Fukuchi Y., Kobayashi I. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 350:1997;1670-1673.
31. Walsh T.R., Bolmstrom A., Qwarnstrom A., Ho P., Wootton M., Howe R.A., MacGowan A.P., Diekema D. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2001;2439-2444.
32. Sieradzki K., Roberts R.B., Haber S.W., Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. New Engl. J. Med. 340:1999;517-523.
33. Ariza J., Pujol M., Cabo J., Pena C., Fernandez N., Linares J., Ayats J., Gudiol F. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet. 353:1999;1587-1588.
34. Heym B., Le Moal M., Armand-Lefevre L., Nicolas-Chanoine M.H. Multilocus sequence typing (MLST) shows that the 'Iberian' clone of methicillin-resistant Staphylococcus aureus has spread to France and acquired reduced susceptibility to teicoplanin. J. Antimicrob. Chemother. 50:2002;323-329.
35. Krzyszton-Russjan J., Gniadkowski M., Polowniak-Pracka H., Hagmajer E., Hryniewicz W. The first Staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland. J. Antimicrob. Chemother. 50:2002;1065-1069.
36. Bierbaum G., Fuchs K., Lenz W., Szekat C., Sahl H.G. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur. J. Clin. Microbiol. Infect. Dis. 18:1999;691-696.
37. Oliveira G.A., Dell'Aquila A.M., Masiero R.L., Levy C.E., Gomes M.S., Cui L., Hiramatsu K., Mamizuka E.M. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect. Control Hosp. Epidemiol. 22:2001;443-448.
38. Kantzanou M., Tassios P.T., Tseleni-Kotsovili A., Legakis N.J., Vatopoulos A.C. Reduced susceptibility to vancomycin of nosocomial isolates of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 43:1999;729-731.
39. Aires de Sousa M., de Lencastre H., Santos Sanches I., Kikuchi K., Totsuka K., Tomasz A. Similarity of antibiotic resistance patterns and molecular typing properties of methicillin-resistant Staphylococcus aureus isolates widely spread in hospitals in New York City and in a hospital in Tokyo, Japan. Microb. Drug Resist. 6:2000;253-258.
40. Roberts R.B., de Lencastre A., Eisner W., Severina E.P., Shopsin B., Kreiswirth B.N., Tomasz A. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. MRSA Collaborative Study Group. J. Infect. Dis. 178:1998;164-171.
41. Sanches I.S., Ramirez M., Troni H., Abecassis M., Padua M., Tomasz A., de Lencastre H. Evidence for the geographic spread of a methicillin-resistant Staphylococcus aureus clone between Portugal and Spain. J. Clin. Microbiol. 33:1995;1243-1246.
42. Dominguez M.A., de Lencastre H., Linares J., Tomasz A. Spread and maintenance of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone during an outbreak of MRSA disease in a Spanish hospital. J. Clin. Microbiol. 32:1994;2081-2087.
43. Teixeira L.A., Resende C.A., Ormonde L.R., Rosenbaum R., Figueiredo A.M., de Lencastre H., Tomasz A. Geographic spread of epidemic multiresistant Staphylococcus aureus clone in Brazil. J. Clin. Microbiol. 33:1995;2400-2404.
44. Leclercq R., Derlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. New Engl. J. Med. 319:1988;157-161.
45. Noble W.C., Virani Z., Cree R.G. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 72:1992;195-198.
46. CDC, Centers for Disease Control (2002) Staphylococcus aureus resistant to vancomycin, United States, 2002. Morbid. Mortal. Wkly Rep. 51, 565-567.
47. CDC, Centers for Disease Control (2002) Public health dispatch: vancomycin-resistant Staphylococcus aureus, Pennsylvania, 2002. Morbid. Mortal. Wkly Rep. 51, 902-903.
48. Udo E.E., Pearman J.W., Grubb W.B. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J. Hosp. Infect. 25:1993;97-108.
49. CDC, Centers for Disease Control (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. Morbid. Mortal. Wkly Rep. 48, 707-710.
50. Salgado C.D., Farr B.M., Calfee D.P. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin. Infect. Dis. 36:2003;131-139.
51. Sanford M.D., Widmer A.F., Bale M.J., Jones R.N., Wenzel R.P. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 19:1994;1123-1128.
52. Groom A.V., Wolsey D.H., Naimi T.S., Smith K., Johnson S., Boxrud D., Moore K.A., Cheek J.E. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. J. Am. Med. Assoc. 286:2001;1201-1205.
53. Maguire G.P., Arthur A.D., Boustead P.J., Dwyer B., Currie B.J. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J. Hosp. Infect. 38:1998;273-281.
54. Aires de Sousa M., de Lencastre H. Evolution of sporadic isolates of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals and their similarities to isolates of community-acquired MRSA. J. Clin. Microbiol. 41:2003;3806-3815.
55. Dufour P., Gillet Y., Bes M., Lina G., Vandenesch F., Floret D., Etienne J., Richet H. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin. Infect. Dis. 35:2002;819-824.
56. Salmenlinna S., Lyytikainen O., Vuopio-Varkila J. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg. Infect. Dis. 8:2002;602-607.
57. O'Brien F.G., Pearman J.W., Gracey M., Riley T.V., Grubb W.B. Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J. Clin. Microbiol. 37:1999;2858-2862.
58. Carbon C. Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. J. Antimicrob. Chemother. 44:(Suppl. A):1999;31-36.
59. Salyers, A.A. and Whitt, D.D. (2002) How bacteria become resistant to antibiotics. In: Bacterial Pathogenesis: A Molecular Approach (Salyers, A.A. and Whitt, D.D., Eds.), pp. 168-184. American Society for Microbiology, Washington, DC.
60. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M., Karchmer A.W. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis. 36:2003;53-59.
61. Engemann J.J., Carmeli Y., Cosgrove S.E., Fowler V.G., Bronstein M.Z., Trivette S.L., Briggs J.P., Sexton D.J., Kaye K.S. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis. 36:2003;592-598.
62. Verhoef J., Beaujean D., Blok H., Baars A., Meyler A., van der Werken C., Weersink A. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 18:1999;461-466.
63. Rubin R.J., Harrington C.A., Poon A., Dietrich K., Greene J.A., Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg. Infect. Dis. 5:1999;9-17.
64. Aubry-Damon H., Legrand P., Brun-Buisson C., Astier A., Soussy C.J., Leclercq R. Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: roles of an infection control program and changes in aminoglycoside use. Clin. Infect. Dis. 25:1997;647-653.
65. Lelievre H., Lina G., Jones M.E., Olive C., Forey F., Roussel-Delvallez M., Nicolas-Chanoine M.H., Bebear C.M., Jarlier V., Andremont A., Vandenesch F., Etienne J. Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J. Clin. Microbiol. 37:1999;3452-3457.
66. Polyzou A., Slavakis A., Pournaras S., Maniatis A.N., Sofianou D., Tsakris A. Predominance of a methicillin-resistant Staphylococcus aureus clone susceptible to erythromycin and several other non-beta-lactam antibiotics in a Greek hospital. J. Antimicrob. Chemother. 48:2001;231-234.
67. Laurent F., Lelievre H., Cornu M., Vandenesch F., Carret G., Etienne J., Flandrois J.P. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J. Antimicrob. Chemother. 47:2001;277-283.
68. Struelens M.J. Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin. Microbiol. Infect. 2:1996;2-11.
69. de Lencastre, H., Santos Sanches, I. and Tomasz, A. (2000) CEM/NET: clinical microbiology and molecular biology in alliance. In: Streptococcus pneumoniae - Molecular Biology and Mechanisms of Disease (Tomasz, A., Ed.), pp. 451-456. Mary Ann Liebert, Larchmont, NY.
70. Murchan S., Kaufmann M.E., Deplano A., de Ryck R., Struelens M., Zinn C.E., Fussing V., Salmenlinna S., Vuopio-Varkila J., El Solh N., Cuny C., Witte W., Tassios P.T., Legakis N., van Leeuwen W., van Belkum A., Vindel A., Laconcha I., Garaizar J., Coombes G., Cookson B. Harmonization of pulsed-field gel electrophoresis for epidemiological typing of methicillin-resistant Staphylococcus aureus by consensus in 10 European centers and its use to plot the spread of related strains. J. Clin. Microbiol. 41:2003;1574-1585.
71. Deplano A., Witte W., van Leeuwen W.J., Brun Y., Struelens M.J. Clonal dissemination of epidemic methicillin-resistant Staphylococcus aureus in Belgium and neighboring countries. Clin. Microbiol. Infect. 6:2000;239-245.
72. Aires de Sousa M., Miragaia M., Sanches I.S., Avila S., Adamson I., Casagrande S.T., Brandileone M.C., Palacio R., Dell'Acqua L., Hortal M., Camou T., Rossi A., Velazquez-Meza M.E., Echaniz-Aviles G., Solorzano-Santos F., Heitmann I., de Lencastre H. Three-year assessment of methicillin-resistant Staphylococcus aureus clones in Latin America from 1996 to 1998. J. Clin. Microbiol. 39:2001;2197-2205.
73. Aires de Sousa M., Bartzavali C., Spiliopoulou I., Santos Sanches I., Crisostomo M.I., de Lencastre H. Two international methicillin-resistant Staphylococcus aureus clones endemic in a university hospital in Patras, Greece. J. Clin. Microbiol. 41:2003;2027-20231.
74. Aires de Sousa M., Crisóstomo M.I., Santos Sanches I., Wu J.S., Fuzhong J., Tomasz A., de Lencastre H. Frequent recovery of a single clonal type of multidrug-resistant Staphylococcus aureus from patients in two hospitals in Taiwan and China. J. Clin. Microbiol. 41:2003;159-163.
75. Simor A.E., Ofner-Agostini M., Bryce E., McGeer A., Paton S., Mulvey M.R. Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance, 1995-1999. J. Infect. Dis. 186:2002;652-660.
76. Moore P.C., Lindsay J.A. Molecular characterization of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16. J. Med. Microbiol. 51:2002;516-521.
77. Seeberg S., Larsson L., Welinder-Olsson C., Sandberg T., Skyman E., Bresky B., Lindqvist A., van Raalte M. [How an outbreak of MRSA in Gothenburg was eliminated: by strict hygienic routines and massive control-culture program]. Lakartidningen. 99:2002;3198-3204.
78. Melo-Cristino, J. and POSGAR (1998) Antimicrobial resistance in staphylococci and enterococci in 10 Portuguese hospitals in 1996 and 1997. Microb. Drug Resist. 4, 319-324.
79. Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A., Nagai Y., Iwama N., Asano K., Naimi T., Kuroda H., Cui L., Yamamoto K., Hiramatsu K. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 359:2002;1819-1827.
80. Oliveira D., Santos-Sanches I., Mato R., Tamayo M., Ribeiro G., Costa D., de Lencastre H. Virtually all methicillin-resistant Staphylococcus aureus (MRSA) infections in the largest Portuguese teaching hospital are caused by two internationally spread multiresistant strains: the 'Iberian' and the 'Brazilian' clones of MRSA. Clin. Microbiol. Infect. 4:1998;373-384.
81. Mulvey M.R., Chui L., Ismail J., Louie L., Murphy C., Chang N., Alfa M. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J. Clin. Microbiol. 39:2001;3481-3485.
82. Amorim M.L., Aires de Sousa M., Sanches I.S., Sá-Leão R., Cabeda J.M., Amorim J.M., de Lencastre H. Clonal and antibiotic resistance profiles of methicillin-resistant Staphylococcus aureus (MRSA) from a Portuguese hospital over time. Microb. Drug Resist. 8:2002;301-309.
83. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:1995;2233-2239.
84. Montesinos I., Salido E., Delgado T., Cuervo M., Sierra A. Epidemiologic genotyping of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis at a university hospital and comparison with antibiotyping and protein A and coagulase gene polymorphisms. J. Clin. Microbiol. 40:2002;2119-2125.
85. Oliveira D.C., de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2002;2155-2161.
86. van Leeuwen W.B., Jay C., Snijders S., Durin N., Lacroix B., Verbrugh H.A., Enright M.C., Troesch A., van Belkum A. Multi-locus sequence typing of Staphylococcus aureus with DNA array technology. J. Clin. Microbiol. 41:2003;3323-3326.
87. Papakyriacou H., Vaz D., Simor A., Louie M., McGavin M.J. Molecular analysis of the accessory gene regulator (agr) locus and balance of virulence factor expression in epidemic methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 181:2000;990-1000.
88. Austin D.J., Anderson R.M. Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales. J. Infect. Dis. 179:1999;883-891.
89. Johnston L., Chui L., Chang N., Macdonald S., McKenzie M., Kennedy W., Haldane D., Bethune R., Taylor G., Hanakowski M., Tyrrell G. Cross-Canada spread of methicillin-resistant Staphylococcus aureus via transplant organs. Clin. Infect. Dis. 29:1999;819-823.
90. Novak F.R., da Silva A.V., Hagler A.N., Figueiredo A.M. Contamination of expressed human breast milk with an epidemic multiresistant Staphylococcus aureus clone. J. Med. Microbiol. 49:2000;1109-1117.
91. Aires de Sousa M., Santos Sanches I., Ferro M.L., de Lencastre H. Epidemiological study of staphylococcal colonization and cross-infection in two West African Hospitals. Microb. Drug Resist. 6:2000;133-141.